The global market for research antibodies should reach $3.0 billion by 2022 from $2.4 billion in 2017 at a compound annual growth rate (CAGR) of 4.8%, from 2017 to 2022.
Report Scope:
This study focuses on the market side of research antibodies rather than the technical side. Different market segments for this specific market are covered. For example, application-based market segments include enzyme-linked immunosorbent assay (ELISA), western blotting (WB), immunohistochemistry (IHC), immunofluorescent staining (IF) and flow cytometry (FC); antibody function-based market segments include primary antibodies and secondary antibodies; antibody clonality-based market segments include polyclonal antibodies and monoclonal antibodies, including oligoclonal antibodies; customer type-based market segments include universities/academic institutions, pharmaceutical/ biotech companies and other types of customers such as governmental research labs and CROs; geography-based market segments include the U.S., Europe, Asia-Pacific and Rest of World. Research and market trends are also extrapolated by analyzing the funding, patent publications and sales trends of major players in the field.
Report Includes:
- 50 data tables
- An overview of the global market for antibodies used in research.
- Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022.
- Segmentation of the market by regions, product types, research applications, species, and major research areas.
- Details concerning end users, purchasing factors, new market trends, and potential growth opportunities that are available.
- Discussion on the factors affecting strategies of antibody companies, the effect of research funding, and third-party quality evaluation systems.
- Analysis of the competitive landscape and key competitors’ market shares.
- Profiles of major companies: Abcam PLC, Abnova, Active Motif, Agilent Technologies, BD Biosciences, Beckman Coulter Inc., Bethyl Laboratories, BioLegend.
Summary
The global market for research antibodies was estimated at about $2.3 billion in 2016, and is expected $3.0 billion in 2022, growing at a compound annual growth rate (CAGR) of 4.8% during the forecast period from 2017 to 2022. All regional markets will experience growth but at different rates. The strong R&D investment in the Asia-Pacific market will bring about the most rapid growth of the research antibody market in this region. The U.S. market, which accounted for about 40% of the global research antibody market in 2016, will continue to be impacted by cuts in research funding and will therefore grow at an estimated CAGR of 3.4% from 2017 through 2022. Although it appears that the overall research antibody market is relatively stable in terms of the overall market size, a dramatic change in the leading antibody manufacturing technologies, including significantly enhanced validation technologies product attributes and competitive landscape, is anticipated in next few years. In other words, the market growth in research antibodies is expected to be more focused on “content” than “volume” in next three to five years.
Key Drivers for Market Growth
This report has identified several key drivers for the growth and changes in the research antibody market, including:
- New discoveries in biological sciences.
- New antibody manufacturing technologies and new antibody types.
- The success of antibody-drug conjugate, which will lead to more antibody-related or antibodyfocused research activities.
- Antibody-based drug discovery and development.
- Increased government funding, particularly in emerging markets.
- Need for further human genomic and proteomic research.
- Need for quality antibodies in the current research community.
- New application-focused technology platforms such as Simple Western from ProteinSimple and Mass Cytometry from Fluidigm.
- “Hot” research areas such as stem cell research, genome editing, exosome biology, epigenetics, neuroscience and cancer research.
- Enhanced antibody validation will improve and potentially increase the antibody uses.
This report identifies key revenue segments for the research antibody market from various aspects. Application-based market segments include enzyme-linked immunosorbent assay (ELISA), western blotting (WB), immunohistochemistry (IHC), immunofluorescent staining (IF) and flow cytometry (FC); antibody function-based market segments include primary antibodies and secondary antibodies; antibody clonality-based market segments include polyclonal antibodies and monoclonal antibodies including oligoclonal antibodies; customer type-based market segments include universities/academic institutions, pharmaceutical/biotech companies and other types of customers, such as governmental
research labs and CROs, etc.; and geography-based market segments include the U.S., Europe, Asia- Pacific and Rest of World.
Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Intended Audience
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
Related BCC Research Reports
Chapter 2 Summary and Highlights
Key Drivers for Market Growth
Chapter 3 Overview of the Research Antibody Market
Introduction
History and Current State
Background of the Antibody and Its Production
Current Status and Issues
Overview of Antibody Technology
Traditional Antibody Generation Technologies
Emerging Antibody Generation Technologies
Antibody Validation Methods
Chapter 4 Research Applications of Antibodies
Introduction
ELISA/ELISPOT
Direct ELISA
Indirect ELISA
Competitive ELISA
Sandwich ELISA
ELISPOT Assays
FluoroSpot Assays
Emerging Technologies or Platforms in ELISA Assays
Western Blot
1-D Gel Electrophoresis
2-D Gel Electrophoresis
Emerging Technologies/Platforms in Western Blot
Immunohistochemistry (IHC)
Flow Cytometry (Including Cell Sorting)
Emerging Technologies or Platforms in Flow Cytometry
Immunocytochemistry/Immunofluorescent Staining
Chromatin Immunoprecipitation (ChIP)
Other Applications of Antibodies
Antibody Arrays
Chapter 5 Segmentation and Forecast of Research Antibody Market
Research Antibody Market Overview
Types of Research Antibodies
Major Players
Market Segments by Region
Segments by Product Type
Segments by Reactive Species
Segments by Host Species
Segments by Clonality Type
Segments by Conjugate
Segments by Research Area
Segments by Application
Segments by User Type
Pitfalls in the Current Research Antibody Market
Non-Specificity
Non-Reproducibility
Market Projections
Chapter 6 Application-Based Markets for Research Antibodies
Application-Based Market Overview
Market for Western Blot Analysis
Market for ELISA
Market for Immunohistochemistry
Market for Immunofluorescent Staining
Chapter 7 Market for Flow Cytometry Analysis
Market Overview
Trends in Flow Cytometric Analysis
Portable Cytometers
Mass Cytometry
Market for Flow Cytometry Instruments
Market for Flow Cytometry Reagents and Consumables
Fluorescent Dyes
Antibodies
Beads
Product Types
Major Players and Growth Strategies
Market Share and Projections
Chapter 8 Market for Antibody Custom Services
Market Overview
Types of Services
Antibody Custom Manufacturing
Antibody Conjugation
Antigen Preparation
Major Players
Market Share and Projections
Chapter 9 Market Trend Analysis
Purchasing Factors Analysis
Third-Party Quality Evaluation Systems
Research Grants
Journal Citations Analysis
Technological Trends in Antibody Production and Application
M&A Activities Related to the Research Antibody Industry
WuXi App Tec Acquires Abgent
Abcam Acquires Epitomics
Agilent Acquires Dako
Affymetrix Acquires eBioscience
Bio-Rad Acquires AbD Serotec
Active Motif Acquires SwitchGear Genomics Inc.
Thermo Fisher Pierce Antibodies Merges with Life Technologies Antibodies
Fluidigm Acquires DVS Sciences
Bio-Techne (R&D Systems) Acquires Novus Biologicals
Bio-Techne (R&D Systems) Acquires ProteinSimple
BioLegend Acquires Covance Antibody Services
German Merck Acquires Sigma
Abcam Acquires Firefly Bioworks
OriGene Technologies Acquires Acris Antibodies GmbH
Abcam Acquires AxioMx
Valiant Co. Ltd. Acquires MP Biomedicals
Thermo Fisher Scientific Acquires Affymetrix
Aviva Systems Biology Acquires GenWay Biotech
Chapter 10 Driving Forces and Limiting Factors of Market Growth
Driving Forces for Market Growth
New Discoveries in Biological Sciences
New Antibody Technologies and Antibody Types
Antibody-Based Drug Discovery and Development
"Hot" Research Areas
Increased Government Funding in Emerging Markets
Need for Further Human Genomic and Proteomic Research
Need for Quality Antibodies in the Current Research Community
Need for Antibody Custom Services
New Application-Focused Technology Platforms
Factors Limiting Market Growth
Research Funding
Validation Technologies
Suppliers
Market Acceptance or Brand Trust
Chapter 11 Company Profiles
Trends Market Research © Copyright 2020. All Rights Reserved.